In patients undergoing percutaneous coronary intervention for acute myocardial infarction (AMI) complicated by cardiogenic shock, use of an intravascular microaxial left ventricular assist device (LVAD) is associated with worse clinical outcomes than use of an intra-aortic balloon pump (IABP). This finding comes from a propensity-matched, registry-based, retrospective cohort study that assessed 28,304 patients, 6.2% of whom received haemodynamic support with an LVAD and 29.9% with an IABP. In the propensity-matched cohort (n = 3,360), LVAD use was associated with a greater risk of in-hospital death (45.0% versus 34.1%) and major bleeding (31.3% versus 16.0%) than IABP use. Importantly, these associations were consistent regardless of the timing of device placement. Additional research is required to understand the optimal device choice for these patients.
References
Original article
Dhruva, S. S. et al. Association of use of an intravascular microaxial left ventricular assist device vs intra-aortic balloon pump with in-hospital mortality and major bleeding among patients with acute myocardial infarction complicated by cardiogenic shock. JAMA https://doi.org/10.1001/jama.2020.0254 (2020)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Huynh, K. LVAD versus balloon pump in patients with AMI. Nat Rev Cardiol 17, 266 (2020). https://doi.org/10.1038/s41569-020-0357-0
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41569-020-0357-0